![]() |
市场调查报告书
商品编码
1988981
焦虑和行为支持产品市场预测至2034年-按产品类型、成分类型、剂型、应用、最终用户和地区分類的全球分析Anxiety & Behaviour Support Products Market Forecasts to 2034 - Global Analysis By Product Type, By Ingredient Type, By Form, By Application, By End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球焦虑和行为支持产品市场规模将达到 21 亿美元,并在预测期内以 9.8% 的复合年增长率增长,到 2034 年将达到 45 亿美元。
焦虑和行为支持产品是旨在减轻宠物压力、攻击性或恐惧相关行为的介入措施。这些产品包括镇静零食、费洛蒙扩散器、穿戴式装置、行为训练辅助工具和互动玩具。它们有助于维护宠物心理健康,改善饲主与宠物之间的关係,并提升宠物的生活品质。人们对宠物情绪健康的日益关注、城市化进程的加速以及因分离和环境变化而引发的行为问题,都在推动市场成长。天然成分的运用、智慧监测以及兽医指导的结合,提高了这些支援产品的有效性、安全性和普及性。
人们越来越关注宠物心理健康
宠物饲主越来越关注宠物的压力、分离焦虑和行为问题。随着宠物越来越“拟人化”,它们的心理健康与身体健康同等重要。社群媒体和兽医宣传活动提高了人们对放鬆疗法的认识。主人愿意投资购买有助于改善宠物行为平衡的营养补充品、零食和设备。这种对心理健康日益增长的关注持续推动着全球市场的扩张。
缺乏关于有效性的临床证据
许多镇静零食和补充剂缺乏标准化的测试来证明其疗效的稳定性。兽医和宠物饲主的怀疑态度阻碍了它们在某些地区的普及。监管机构要求在核准新配方之前提供更有力的证据。消费者需求与科学检验之间的这种差距造成了市场的不确定性。因此,缺乏临床支持仍然是阻碍其更广泛接受度的因素。
人工智慧驱动的行为监测设备
智慧项圈和穿戴式追踪器能够监测心率和活动量等压力指标。人工智慧演算法可提供个人化的镇静方案和营养补充建议。透过与行动应用程式集成,饲主可以即时追踪宠物的行为模式。兽医诊所可以利用这些资讯来制定个人化的治疗方案。这项技术创新可望加速高级产品的普及,并提升市场信誉。
对膳食补充剂的监管限制
地方政府对宠物保健品製定了严格的指导方针,限制了产品的上市。各国不同的核准流程也阻碍了全球扩张。企业为了达到合规标准,必须承担延误和额外成本。虚假宣传和夸大广告可能导致产品召回,损害品牌声誉。这些复杂的监管问题持续阻碍着该行业的成长。
新冠疫情对焦虑和行为支持产品市场产生了复杂的影响。一方面,供应链中断影响了镇静补充剂和设备的生产和分销。另一方面,疫情封锁期间宠物饲养量的增加推高了对行为支持解决方案的需求。由于居家时间增多,饲主更重视宠物的心理需求。实体店受到限制,线上销售管道迅速发展。整体而言,疫情加速了数位化进程,同时也凸显了供应链的脆弱性。
在预测期内,镇静零食细分市场预计将占据最大的市场份额。
由于其便利性、易获取性和易于服用,预计在预测期内,镇静零食将占据最大的市场份额。宠物饲主更倾向于选择零食而非营养补充剂,因为偏好且具有功能性优势。製造商正在开发使用洋甘菊、缬草根和麻提取物等天然成分的产品。镇静零食的零售市场渗透率高于其他行为支持产品。人们对宠物压力管理意识的不断提高,进一步推动了该细分市场的需求。
在预测期内,兽医院细分市场预计将呈现最高的复合年增长率。
在预测期内,由于人们越来越依赖专家指导来解决行为问题,兽医院领域预计将呈现最高的成长率。兽医院正在将镇静剂补充剂和监测设备纳入治疗方案。兽医进行的宣传宣传活动不断提高消费者对这些产品的信心。兽医院也发挥分销中心的作用,提高了产品的知名度和信誉。兽医专业人员的个人化建议正在推动高级产品的普及。
在预测期内,北美预计将占据最大的市场份额,这主要得益于其较高的宠物拥有率和强大的购买力。美国和加拿大的消费者对行为支持产品的接受度非常高。知名品牌和兽医网络正在推动镇静零食和营养补充品的普及。与其他地区相比,北美高级产品的零售渗透率更高。强而有力的品牌宣传活动和数位行销正在助力市场进一步成长。这些因素共同作用,将确保北美在市场份额方面保持领先地位。
在预测期内,受宠物心理健康意识不断提高和相关法规结构的支持,欧洲地区预计将呈现最高的复合年增长率。德国、法国和英国等国家对行为支持解决方案的需求正在增加。欧洲消费者对天然环保的镇静产品表现出极高的兴趣。兽医的推荐和临床试验正在提升产品在该地区的信誉度。本土Start-Ups正携创新的人工智慧监测设备进军市场。
According to Stratistics MRC, the Global Anxiety & Behaviour Support Products Market is accounted for $2.1 billion in 2026 and is expected to reach $4.5 billion by 2034 growing at a CAGR of 9.8% during the forecast period. Anxiety & Behaviour Support Products are interventions for pets designed to reduce stress, aggression, or fear-related behaviors. They include calming treats, pheromone diffusers, wearable devices, behavioral training aids, and interactive toys. These products support mental health, improve owner-pet relationships, and enhance quality of life. Increasing awareness of pets' emotional wellbeing, the rise of urban living, and behavioral issues due to separation or environmental changes drive market growth. Integration of natural ingredients, smart monitoring, and veterinary guidance enhances efficacy, safety, and adoption of these support products.
Increasing awareness of pet mental health
Pet owners are increasingly recognizing stress, separation anxiety, and behavioural issues in their pets. Rising humanization of pets has led to greater emphasis on emotional well-being alongside physical health. Social media and veterinary campaigns are amplifying awareness about calming solutions. Owners are more willing to invest in supplements, treats, and devices that improve behavioural balance. This heightened focus on mental health continues to fuel market expansion globally.
Limited clinical evidence for efficacy
Many calming treats and supplements lack standardized trials to prove consistent results. Skepticism among veterinarians and pet owners slows adoption in certain regions. Regulatory bodies demand stronger evidence before approving new formulations. This gap between consumer demand and scientific validation creates uncertainty in the market. As a result, limited clinical backing continues to hinder broader acceptance.
AI-based behavioral monitoring devices
Smart collars and wearable trackers can monitor stress indicators such as heart rate and activity levels. AI algorithms provide personalized recommendations for calming routines and supplements. Integration with mobile apps allows owners to track behavioural patterns in real time. Veterinary clinics can use these insights to design tailored treatment plans. This technological innovation is expected to accelerate premium adoption and strengthen market credibility.
Regulatory restrictions on supplements
Authorities in different regions impose strict guidelines on pet supplements, limiting product launches. Variations in approval processes across countries create barriers for global expansion. Companies face delays and added costs in meeting compliance standards. Mislabeling or exaggerated claims can lead to product recalls, damaging brand reputation. This regulatory complexity continues to challenge the industry's growth trajectory.
The Covid-19 pandemic had mixed effects on the anxiety and behaviour support products market. On one hand, supply chain disruptions affected production and distribution of calming supplements and devices. On the other hand, increased pet adoption during lockdowns boosted demand for behavioural support solutions. Owners spending more time at home became more attentive to their pets' emotional needs. Online sales channels grew rapidly as physical retail faced restrictions. Overall, the pandemic accelerated digital adoption while highlighting supply chain vulnerabilities.
The calming treats segment is expected to be the largest during the forecast period
The calming treats segment is expected to account for the largest market share during the forecast period as they are convenient, widely available, and easy to administer. Pet owners prefer treats over supplements due to their palatability and functional benefits. Manufacturers are innovating with natural ingredients such as chamomile, valerian root, and hemp extracts. Retail penetration of calming treats is higher compared to other behavioural support products. Rising awareness of stress management in pets further strengthens demand for this segment.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing reliance on professional guidance for behavioural issues. Clinics are integrating calming supplements and monitoring devices into treatment plans. Rising awareness campaigns by veterinarians are boosting consumer trust in these products. Clinics also serve as distribution hubs, enhancing product visibility and credibility. Personalized recommendations from veterinary professionals encourage premium adoption.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong purchasing power. Consumers in the U.S. and Canada are highly receptive to behavioural support products. Established brands and veterinary networks are driving adoption of calming treats and supplements. Retail penetration of premium products is higher in North America compared to other regions. Strong awareness campaigns and digital marketing further support growth. These factors collectively ensure North America's dominance in market share.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by rising awareness of pet mental health and supportive regulatory frameworks. Countries such as Germany, France, and the UK are witnessing increased demand for behavioural support solutions. European consumers are highly receptive to natural and eco-friendly calming products. Veterinary endorsements and clinical trials are strengthening credibility in the region. Local startups are entering the market with innovative AI-based monitoring devices.
Key players in the market
Some of the key players in Anxiety & Behaviour Support Products Market include Nestle Purina PetCare, Mars Petcare, Ceva Sante Animale, Zylkene (Vetoquinol), ThunderShirt, Adaptil (Ceva), Pet Naturals of Vermont, VetriScience Laboratories, Rescue Remedy Pets, HempMy Pet, Honest Paws, Bach Flower Remedies, PetHonesty, NaturVet and Only Natural Pet.
In November 2025, Purina Pro Plan Veterinary announced a partnership with Ease, an online platform for veterinary behaviour specialty care. This collaboration gives veterinary clinics free access to board-certified behaviourists, expanding Purina's support mission to address pet anxiety and behavioural challenges through professional guidance.
In November 2025, Ceva unveiled its Douxo Spa product line for pets during the holiday season. While primarily a dermatology and wellness product, it complements Ceva's behavioural support portfolio by addressing comfort and wellbeing, which are closely linked to stress reduction in pets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.